Researchers utilizing immunoassays throughout the biotherapeutics development process are looking for:
We present three examples that show how Gyrolab systems contribute to developing biopharmaceutical drugs faster and with less cost and effort.
Case study 1: Obtaining an entire PK profile from a single mouse
Case study 2: Earlier and more sensitive detection of drug-induced kidney toxicity in preclinical studies
Case study 3: Ramping up Phase II/III PK studies to meet critical deadlines
If you have problems downloading the poster please contact: